BHSRX
Price
$62.44
Change
+$0.33 (+0.53%)
Updated
Feb 4 closing price
Net Assets
6.49B
JFNIX
Price
$81.88
Change
-$0.11 (-0.13%)
Updated
Feb 4 closing price
Net Assets
5.36B
Interact to see
Advertisement

BHSRX vs JFNIX

Header iconBHSRX vs JFNIX Comparison
Open Charts BHSRX vs JFNIXBanner chart's image
BlackRock Health Sciences Opps R
Price$62.44
Change+$0.33 (+0.53%)
VolumeN/A
Net Assets6.49B
Janus Henderson Global Life Sciences I
Price$81.88
Change-$0.11 (-0.13%)
VolumeN/A
Net Assets5.36B
BHSRX vs JFNIX Comparison Chart in %
View a ticker or compare two or three
VS
BHSRX vs. JFNIX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHSRX is a Buy and JFNIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BHSRX has more cash in the bank: 6.49B vs. JFNIX (5.36B). JFNIX pays higher dividends than BHSRX: JFNIX (0.45) vs BHSRX (0.10). BHSRX was incepted earlier than JFNIX: BHSRX (14 years) vs JFNIX (17 years). BHSRX (1.45) is less costly to investors than JFNIX (0.77). BHSRX is a more actively managed with annual turnover of: 43.00 vs. JFNIX (30.00). BHSRX has a lower initial minimum investment than JFNIX: BHSRX (100) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : 14.52 vs. BHSRX (-3.16). JFNIX return over 5 years is better than : 14.66 vs. BHSRX (-14.83).
BHSRXJFNIXBHSRX / JFNIX
Total Expense Ratio1.440.77187%
Annual Report Gross Expense Ratio1.450.77188%
Fund Existence14 years17 years-
Gain YTD0.6770.88776%
Front LoadN/AN/A-
Min. Initial Investment10025004%
Min. Initial Investment IRAN/AN/A-
Net Assets6.49B5.36B121%
Annual Yield % from dividends0.100.4522%
Returns for 1 year-3.1614.52-22%
Returns for 3 years-0.7223.72-3%
Returns for 5 years-14.8314.66-101%
Returns for 10 years51.8499.1252%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FASEX55.820.52
+0.94%
Nuveen Mid Cap Value Opportunities A
REIZX15.300.05
+0.33%
Third Avenue International RE Val Z
TWAAX13.40N/A
N/A
Thrivent International Equity A
BRXCX18.18-0.03
-0.16%
MFS Blended Research Intl Eq C
HCAIX98.58-1.62
-1.62%
Harbor Capital Appreciation Inv